The British government is weighing a groundbreaking initiative that would permit private enterprises to monetise NHS patient data, marking a significant shift in healthcare data management. Labour leader Keir Starmer
Healthcare8- Page
168Articles
British pharmaceutical giant GSK has struck a significant deal worth up to $1.15 billion to acquire IDRx, a Massachusetts-based biopharmaceutical company, strengthening its position in the oncology sector. The FTSE
Shares in Oxford Nanopore Technologies jumped 8.9 per cent today after the British gene sequencing innovator reported robust revenue growth and reaffirmed its path to profitability. The FTSE 250 company
In a significant move that marks the largest biotech acquisition since 2023, Johnson & Johnson has announced its agreement to purchase neuroscience drugmaker Intra-Cellular Therapies for £14.6 billion. The New
In a devastating blow to investor confidence, Moderna’s shares experienced a dramatic decline of up to 22 per cent on Monday following disappointing sales forecasts from the US biotech giant.
The struggling consumer healthcare company Alliance Pharma appears poised to exit London’s junior stock exchange following a £350 million takeover bid from activist investor Dbay Advisors. The Isle of Man-based
A groundbreaking series A funding round has positioned London-based Verdiva Bio at the forefront of the obesity treatment sector, securing an impressive $411 million investment. This remarkable achievement stands as
A landmark research initiative analysing blood proteins could catalyse significant advancements in disease treatment and prevention, presenting substantial opportunities for healthcare sector investors. The extensive UK-based study, backed by 14
British pharmaceutical giant GSK is in advanced negotiations to acquire IDRx, a Massachusetts-based biotechnology company, in a deal valued at approximately $1 billion. The announcement is expected to coincide with
The National Health Service faces unprecedented pressure as nine hospitals across England declare critical incidents, with patients experiencing wait times of up to two days in Accident and Emergency departments.
Novo Nordisk, the Danish pharmaceutical powerhouse, has invested hundreds of thousands of pounds in sponsorship deals with major UK pharmacy chains, including Boots and Lloyds, to enhance sales of its
The UK pharmacy sector witnessed a significant wave of consolidation as nearly one in ten pharmacies were acquired through mergers and acquisitions in the 12 months to June 2024, amid
Britain’s children are facing an unprecedented health crisis as poor nutrition and rising obesity rates continue to plague the nation’s youth. Recent NHS data reveals a stark reality: one in
British pharmaceutical giant AstraZeneca has distributed approximately £45 million to Russian healthcare professionals and organisations since the outbreak of the Ukraine war, despite mounting UK military support for Kyiv. The
The aggressive marketing of weight-loss injections to British consumers has sparked significant concern amongst healthcare experts, who are witnessing what they describe as a “wild west” approach to pharmaceutical promotion.
Critical concerns are emerging regarding the National Health Service’s operational effectiveness as it awaits Wes Streeting’s comprehensive 10-year reform plan. The Institute for Public Policy Research (IPPR) has raised significant
